Laboratory Corporation of America Holdings / "Executive Compensation" | Tables in SEC filings

LH Laboratory Corporation of America Holdings

Definitive proxy

EXECUTIVE COMPENSATION

Glenn A. Eisenberg	Voluntary Termination		Early Retirement		Normal Retirement		Involuntary Not for Cause or Good Reason Termination		For Cause Termination	Change-in- Control		Disability(2)		Death
Severance (Related to Base Compensation)	$	-	$	-	$	-	$	1,634,000	$-	$	1,634,000	$	-	$	-
Severance (Related to Annual Incentive Cash Payments)	$	-	$	-	$	-	$	2,250,751	$-	$	2,250,751	$	-	$	-
Stock Options	$	100,699	$	100,699	$	100,699	$	100,699	$-	$	100,699	$	100,699	$	100,699
Restricted Stock Units	$	5,830,444	$	5,830,444	$	5,830,444	$	8,189,930	$-	$	8,189,930	$	7,719,832	$	7,719,832
Performance Shares	$	5,036,636	$	5,036,636	$	5,036,636	$	7,396,122	$-	$	5,881,158	$	5,881,158	$	5,881,158
Health & Welfare Benefits	$	-	$	-	$	-	$	23,600	$-	$	23,600	$	1,800,000	$	1,500,000
TOTAL	$	10,967,779	$	10,967,779	$	10,967,779	$	19,595,102	$-	$	18,080,138	$	15,501,689	$	15,201,689
Brian J. Caveney	Voluntary Termination		Early Retirement		Normal Retirement		Involuntary Not for Cause or Good Reason Termination		For Cause Termination	Change-in- Control		Disability(2)		Death
Severance (Related to Base Compensation)		$-		$-		$-	$	1,300,000	$-	$	1,300,000	$	-	$	-
Severance (Related to Annual Incentive Cash Payments)		$-		$-		$-	$	1,168,446	$-	$	1,168,446	$	-	$	-
Stock Options		$-		$-		$-	$	49,938	$-	$	88,108	$	88,108	$	88,108
Restricted Stock Units		$-		$-		$-	$	3,049,413	$-	$	3,448,120	$	3,448,120	$	3,448,120
Performance Shares		$-		$-		$-	$	1,475,668	$-	$	2,281,093	$	2,281,093	$	2,281,093
Health & Welfare Benefits		$-		$-		$-	$	23,600	$-	$	23,600	$	2,100,000	$	1,300,000
TOTAL		$-		$-		$-	$	7,067,063	$-	$	8,309,367	$	7,917,321	$	7,117,321
Anita Z. Graham	Voluntary Termination		Early Retirement		Normal Retirement		Involuntary Not for Cause or Good Reason Termination		For Cause Termination	Change-in- Control		Disability(2)		Death
Severance (Related to Base Compensation)		$-		$-		$-	$	1,120,000	$-	$	1,120,000	$	-	$	-
Severance (Related to Annual Incentive Cash Payments)		$-		$-		$-	$	952,000	$-	$	952,000	$	-	$	-
Stock Options		$-		$-		$-	$	19,501	$-	$	58,521	$	58,521	$	58,521
Restricted Stock Units		$-		$-		$-	$	84,639	$-	$	253,459	$	253,459	$	253,459
Performance Shares		$-		$-		$-	$	422,837	$-	$	757,398	$	757,398	$	757,398
Health & Welfare Benefits		$-		$-		$-	$	23,600	$-	$	23,600	$	2,100,000	$	1,120,000
TOTAL		$-		$-		$-	$	2,622,577	$-	$	3,164,978	$	3,169,378	$	2,189,378

Mark S. Schroeder		Voluntary Termination					Early Retirement					Normal Retirement					Involuntary Not for Cause or Good Reason Termination					For Cause Termination					Change-in- Control					Disability(2)					Death
Severance (Related to Base Compensation)			$	-			$	-			$	-			$	1,300,000			$	-			$	1,300,000			$	-			$	-	Severance (Related to Annual Incentive Cash Payments)			$	-			$	-			$	-			$	1,560,614			$	-			$	1,560,614			$	-			$	-	Stock Options			$	53,873			$	53,873			$	53,873			$	53,873			$	-			$	99,968			$	99,968			$	99,968	Restricted Stock Units			$	3,061,111			$	3,061,111			$	3,061,111			$	3,061,111			$	-			$	3,483,904			$	3,483,904			$	3,483,904	Performance Shares			$	1,540,700			$	1,540,700			$	1,540,700			$	1,540,700			$	-			$	2,393,716			$	2,393,716			$	2,393,716	Health & Welfare Benefits			$	-			$	-			$	-			$	23,600			$	-			$	23,600			$	1,500,000			$	1,300,000	TOTAL			$	4,655,684				$	4,655,684				$	4,655,684				$	7,539,898				$	-				$	8,861,802				$	7,477,588				$	7,277,588

Name		Fees Earned or Paid in Cash ($)(1)					Restricted Stock Unit Awards ($)(2)					All Other Compensation ($)(3)					Total ($)
KERRII B. ANDERSON			$	130,714			$	209,921			$	93			$	340,728	JEAN-LUC BÉLINGARD			$	120,000			$	209,921			$	389			$	330,310	JEFFREY A. DAVIS			$	134,286			$	209,921			$	93			$	344,300	D. GARY GILLILAND, M.D., PH.D.			$	120,000			$	209,921			$	93			$	330,014	KIRSTEN M. KLIPHOUSE			$	120,000			$	209,921			$	93			$	330,014	GARHENG KONG, M.D., PH.D.			$	165,714			$	209,921			$	93			$	375,728	PETER M. NEUPERT			$	147,857			$	209,921			$	93			$	357,871	RICHELLE P. PARHAM			$	131,429			$	209,921			$	93			$	341,433	PAUL B. ROTHMAN, M.D.			$	68,242			$	140,087			$	95			$	208,424	KATHRYN E. WENGEL			$	120,000			$	209,921			$	93			$	330,014	R. SANDERS WILLIAMS, M.D.			$	140,000			$	209,921			$	93			$	350,014

				Option Awards											Stock Awards
Name	Grant Date			Number of Securities Underlying Unexercised Options (#) Exercisable(1)			Number of Securities Underlying Unexercised Options (#) Unexercisable(1)				Option Exercise Price ($)			Option Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#)(2)			Market Value of Shares or Units of Stock That Have Not Vested ($)(3)		Equity Incentive Plan Awards: Number Unearned Shares, Units or Other Rights That Have Not Vested (#)(4,5,6)			Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)(3)
BRIAN J. CAVENEY			2/12/2018		3,011		-		$	151.06			2/11/2028
		2/12/2019		3,903		-		$	131.43			2/11/2029
		2/4/2020		8,142		-		$	163.63			2/3/2030
		2/2/2021		3,418		1,712		$	209.25			2/1/2031
		2/11/2022		1,673		3,346		$	247.68			2/10/2032
		2/7/2023		-		4,907		$	221.67			2/6/2033
		5/5/2023		-		1,115		$	200.7			5/4/2033
		2/2/2021													495	$	112,509
		2/2/2021													11,556	$	2,626,563
		2/11/2022													945	$	214,789
		2/7/2023													1,551	$	352,527
		5/5/2023													335	$	76,142
		2/11/2022																		8,478	$	1,926,964		2/7/2023							9,304	$	2,114,706	5/5/2023	1,986	$	451,397	ANITA Z. GRAHAM	4/5/2023	-	3,346	$	209.8	4/4/2033
		4/5/2023													1,105	$	251,155
		4/5/2023																		6,604	$	1,501,023	MARK S. SCHROEDER		2/7/2017	2,119	-	$	117.09	2/6/2027
		2/12/2018		3,011		-		$	151.06			2/11/2028
		2/12/2019		3,903		-		$	131.43			2/11/2029
		2/4/2020		8,142		-		$	163.63			2/3/2030
		2/2/2021		3,418		1,712		$	209.25			2/1/2031
		2/11/2022		1,673		3,346		$	247.68			2/10/2032
		2/7/2023		-		4,907		$	221.67			2/6/2033
		5/5/2023		-		1,561		$	200.70			5/4/2033
		2/2/2021													495	$	112,509
		2/2/2021													11,556	$	2,626,563
		2/11/2022													945	$	214,789
		2/7/2023													1,551	$	352,527
		5/5/2023													491	$	111,599
		2/11/2022																		8,478	$	1,926,964		2/7/2023							9,304	$	2,114,706	5/5/2023	2,968	$	674,596	PAUL R. KIRCHGRABER	2/2/2021	1,712	-	$	209.25	2/1/2031
		2/11/2022		3,792		-		$	247.68			2/10/2032
		2/7/2023		1,858		-		$	221.67			2/6/2033
		2/2/2021													10,272	$	2,334,723
		2/11/2022																	$	5,400	$	1,227,366		2/7/2023							2,368	$	538,222

Name		Grant Date Value at Threshold Performance ($)					Grant Date Value at Superior Performance ($)
ADAM H. SCHECHTER			$	3,455,064			$	13,820,729	GLENN A. EISENBERG			$	942,656			$	3,770,622	BRIAN J. CAVENEY			$	667,045			$	2,668,651	ANITA Z. GRAHAM			$	390,252			$	1,561,007	MARK S. SCHROEDER			$	725,192			$	2,900,769	PAUL R. KIRCHGRABER			$	627,570			$	2,510,281	THOMAS H. PIKE			$	-			$	-

Table search / Laboratory Corporation of America Holdings / "Executive Compensation"

5 results

Top filers

Top filing types

Recent filing years